MGTX
MeiraGTx Holdings PLCNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$840.42M
P/E Ratio
—
EPS
$-1.42
Beta
1.28
52W High
$11.85
52W Low
$4.55
50-Day MA
$8.38
200-Day MA
$8.12
Dividend Yield
—
Profit Margin
-140.30%
Forward P/E
1.61
PEG Ratio
—
About MeiraGTx Holdings PLC
MeiraGTx Holdings plc, a clinical-stage gene therapy company, focused on developing treatments for patients living with serious illnesses. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $81.39M |
| Gross Profit (TTM) | $76.55M |
| EBITDA | $-93.43M |
| Operating Margin | 35.10% |
| Return on Equity | -368.20% |
| Return on Assets | -25.80% |
| Revenue/Share (TTM) | $1.01 |
| Book Value | $-0.07 |
| Price-to-Book | 225.31 |
| Price-to-Sales (TTM) | 10.33 |
| EV/Revenue | 10.66 |
| EV/EBITDA | -3.29 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 252.30% |
| Shares Outstanding | $92.56M |
| Float | $46.63M |
| % Insiders | 17.70% |
| % Institutions | 58.21% |
Historical Volatility
HV 10-Day
102.40%
HV 20-Day
104.35%
HV 30-Day
89.70%
HV 60-Day
71.12%
HV Rank
95.6%
Volatility is currently expanding
Analyst Ratings
Consensus ($27.88 target)
2
Strong Buy6
BuyData last updated: 4/29/2026